Resultados de la búsqueda 431-440 of 7777 for Raised phosphate

  1. Mayo Clinic Physician Update - June 2023

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  3. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    ... high heritability. The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...